Replies to post #12859 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Biolex Acquires Full Worldwide Rights to Locteron:
#msg-32662307.

[DewDiligence]

Index to Posts on Biolex

[Updated entries on Locteron.]

Biolex has a production platform for protein drugs that uses transgenic plants. Here's a partial list of relevant posts:

CD20 and other mAb programs
#msg-25179852 CD20/Rituxan FoB program
#msg-26942457 Collaboration with Merck Serono
#msg-19450622 Collaboration with Genmab
#msg-15116312 Homogeneity of glycosylation
#msg-5919466 ‘Plantibody’ patent

Locteron program in HCV
#msg-32662307 Biolex acquires full rights to Locteron
#msg-28786162 Phase-2a Locteron data

Corporate and miscellaneous
#msg-21229000 BLX-155 clot-buster program
#msg-32662762 Biolex raises $60M for VC’s
#msg-26487825 IPO withdrawal (2/08)